BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29921661)

  • 21. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
    Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
    Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
    Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
    Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
    Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
    J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.
    Fujimaru T; Mori T; Sekine A; Mandai S; Chiga M; Kikuchi H; Ando F; Mori Y; Nomura N; Iimori S; Naito S; Okado T; Rai T; Hoshino J; Ubara Y; Uchida S; Sohara E
    Clin Genet; 2018 Jul; 94(1):125-131. PubMed ID: 29520754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants.
    Raj S; Singh RG; Das P
    Mutat Res; 2020; 821():111718. PubMed ID: 32823016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scribble influences cyst formation in autosomal-dominant polycystic kidney disease by regulating Hippo signaling pathway.
    Xu D; Lv J; He L; Fu L; Hu R; Cao Y; Mei C
    FASEB J; 2018 Aug; 32(8):4394-4407. PubMed ID: 29529391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De-repression of Pkd1 or Pkd2 attenuates ADPKD.
    Carney EF
    Nat Rev Nephrol; 2022 Nov; 18(11):679. PubMed ID: 36151325
    [No Abstract]   [Full Text] [Related]  

  • 29. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
    Kurbegovic A; Trudel M
    Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Three Novel Frameshift Mutations in the PKD1 Gene in Iranian Families with Autosomal Dominant Polycystic Kidney Disease Using Efficient Targeted Next-Generation Sequencing.
    Ranjzad F; Aghdami N; Tara A; Mohseni M; Moghadasali R; Basiri A
    Kidney Blood Press Res; 2018; 43(2):471-478. PubMed ID: 29590654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.
    Losekoot M; Ruivenkamp CA; Tholens AP; Grimbergen JE; Vijfhuizen L; Vermeer S; Dijkman HB; Cornelissen EA; Bongers EM; Peters DJ
    J Med Genet; 2012 Jan; 49(1):37-40. PubMed ID: 22114106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
    Kurbegovic A; Trudel M
    Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease.
    Xu Y; Li A; Wu G; Liang C
    Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
    Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
    BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).
    Veldhuisen B; Spruit L; Dauwerse HG; Breuning MH; Peters DJ
    Eur J Hum Genet; 1999 Dec; 7(8):860-72. PubMed ID: 10602361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular advances in autosomal dominant polycystic kidney disease.
    Gallagher AR; Germino GG; Somlo S
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An autopsy case of subarachnoid hemorrhage due to ruptured cerebral aneurysm associated with polycystic kidney disease caused by a novel PKD1 mutation.
    Soejima M; Sugita Y; Koda Y
    Forensic Sci Int; 2014 Sep; 242():e18-e21. PubMed ID: 25022697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.